As of 2024-12-15, the Fair Value of Rocket Pharmaceuticals Inc (RCKT) is -14.16 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 12.02 USD, the upside of Rocket Pharmaceuticals Inc is -217.76%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -77.27 | -139.70 | -169.07 | -221.86 | -245.59 | -170.70 |
| YoY growth | -3.69% | -80.79% | -21.02% | -31.22% | -10.70% | -29.49% |
| Market Cap (mil) | 1,095.74 |
| P/E | |
| Forward P/E |
| EPS | -2.83 |
| Avg earnings growth rate | -29.49% |
| TTM earnings | -258.08 |